Evaluate the anti-tumor efficacy and safety of platinum-based doublet chemotherapy combined with tislelizumab and voriconazole as neoadjuvant therapy in patients with resectable stage II-III non-small cell lung cancer (NSCLC) with pulmonary Aspergillus colonization: a prospective, exploratory, single-arm phase II clinical study

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 52e936f8d490d5b27ee6ddf36ada5f8542d55f59
First added on: Sep 12, 2026